489 related articles for article (PubMed ID: 17085937)
1. Interaction of plasma homocysteine and thyroid hormone concentrations in the pathogenesis of the slow coronary flow phenomenon.
Evrengul H; Tanriverdi H; Enli Y; Kuru O; Seleci D; Bastemir M; Kilic A; Kaftan A; Kilic M
Cardiology; 2007; 108(3):186-92. PubMed ID: 17085937
[TBL] [Abstract][Full Text] [Related]
2. Elevated homocysteine levels in patients with slow coronary flow: relationship with Helicobacter pylori infection.
Evrengul H; Tanriverdi H; Kuru O; Enli Y; Yuksel D; Kilic A; Kaftan A; Kirac S; Kilic M
Helicobacter; 2007 Aug; 12(4):298-305. PubMed ID: 17669101
[TBL] [Abstract][Full Text] [Related]
3. Elevated level of plasma homocysteine in patients with slow coronary flow.
Riza Erbay A; Turhan H; Yasar AS; Ayaz S; Sahin O; Senen K; Sasmaz H; Yetkin E
Int J Cardiol; 2005 Jul; 102(3):419-23. PubMed ID: 16004886
[TBL] [Abstract][Full Text] [Related]
4. Effect of homocysteine-induced oxidative stress on endothelial function in coronary slow-flow.
Tanriverdi H; Evrengul H; Enli Y; Kuru O; Seleci D; Tanriverdi S; Tuzun N; Kaftan HA; Karabulut N
Cardiology; 2007; 107(4):313-20. PubMed ID: 17264512
[TBL] [Abstract][Full Text] [Related]
5. Acute phase reactants in patients with coronary slow flow phenomenon.
Madak N; Nazlı Y; Mergen H; Aysel S; Kandaz M; Yanık E; Cekdemir D; Tavlı T
Anadolu Kardiyol Derg; 2010 Oct; 10(5):416-20. PubMed ID: 20929698
[TBL] [Abstract][Full Text] [Related]
6. Impaired coronary blood flow may be related to elevated homocysteine levels in patients with metabolic syndrome.
Alihanoglu YI; Yildiz BS; Özcan EE; Kilic ID; Kuru DS; Taskoylu O; Tanriverdi H; Kaftan HA; Evrengul H
Wien Klin Wochenschr; 2015 Nov; 127(21-22):864-870. PubMed ID: 26377176
[TBL] [Abstract][Full Text] [Related]
7. The role of adrenergic activity in slow coronary flow and its relationship to TIMI frame count.
Yazici M; Demircan S; Durna K; Sahin M
Angiology; 2007; 58(4):393-400. PubMed ID: 17652227
[TBL] [Abstract][Full Text] [Related]
8. Elevated plasma homocysteine level in slow coronary flow.
Barutcu I; Sezgin AT; Sezgin N; Gullu H; Esen AM; Topal E; Ozdemir R
Int J Cardiol; 2005 May; 101(1):143-5. PubMed ID: 15860399
[TBL] [Abstract][Full Text] [Related]
9. The effects of endothelial dysfunction and inflammation on slow coronary flow.
Arı H; Arı S; Erdoğan E; Tiryakioğlu O; Huysal K; Koca V; Bozat T
Turk Kardiyol Dern Ars; 2010 Jul; 38(5):327-33. PubMed ID: 21200102
[TBL] [Abstract][Full Text] [Related]
10. Increased plasma soluble adhesion molecules; ICAM-1, VCAM-1, and E-selectin levels in patients with slow coronary flow.
Turhan H; Saydam GS; Erbay AR; Ayaz S; Yasar AS; Aksoy Y; Basar N; Yetkin E
Int J Cardiol; 2006 Apr; 108(2):224-30. PubMed ID: 16002164
[TBL] [Abstract][Full Text] [Related]
11. Mean platelet volume in patients with slow coronary flow and its relationship with clinical presentation.
Nurkalem Z; Alper AT; Orhan AL; Zencirci AE; Sari I; Erer B; Aksu HU; Ergün DS; Yilmaz HY; Eren M
Turk Kardiyol Dern Ars; 2008 Sep; 36(6):363-7. PubMed ID: 19155638
[TBL] [Abstract][Full Text] [Related]
12. Carotid intima-media thickness in coronary slow flow: relationship with plasma homocysteine levels.
Tanriverdi H; Evrengul H; Tanriverdi S; Kuru O; Seleci D; Enli Y; Kaftan A; Kilic M
Coron Artery Dis; 2006 May; 17(4):331-7. PubMed ID: 16707955
[TBL] [Abstract][Full Text] [Related]
13. Clinical and coronary angiographic characteristics of patients with coronary slow flow.
Yilmaz H; Demir I; Uyar Z
Acta Cardiol; 2008 Oct; 63(5):579-84. PubMed ID: 19014000
[TBL] [Abstract][Full Text] [Related]
14. Early sign of atherosclerosis in slow coronary flow and relationship with angiotensin-converting enzyme I/D polymorphism.
Tanriverdi H; Evrengul H; Mergen H; Acar C; Seleci D; Kuru O; Tanriverdi S; Kaftan A
Heart Vessels; 2007 Jan; 22(1):1-8. PubMed ID: 17285438
[TBL] [Abstract][Full Text] [Related]
15. Plasma homocysteine is associated with ischemic findings without organic stenosis in patients with slow coronary flow.
Yurtdaş M; Özcan IT; Seyis AS; Çamsarı A; Ciçek D
J Cardiol; 2013 Feb; 61(2):138-43. PubMed ID: 23159204
[TBL] [Abstract][Full Text] [Related]
16. Increased neopterin levels and its association with angiographic variables in patients with slow coronary flow: an observational study.
Varol E; Gülcan M; Aylak F; Ozaydın M; Sütçü R; Erdoğan D; Doğan A
Anadolu Kardiyol Derg; 2011 Dec; 11(8):692-7. PubMed ID: 22088857
[TBL] [Abstract][Full Text] [Related]
17. [Thyroid hormone changes in women with pre-eclampsia and its relationship with the presence of pre-eclampsia].
Zhou J; Du J; Ma B; Liu X; Qiu H; Li J; Wang X
Zhonghua Fu Chan Ke Za Zhi; 2014 Feb; 49(2):109-13. PubMed ID: 24739642
[TBL] [Abstract][Full Text] [Related]
18. Increased thrombolysis in myocardial infarction frame count in patients with myocardial infarction and normal coronary arteriogram: a possible link between slow coronary flow and myocardial infarction.
Yetkin E; Turhan H; Erbay AR; Aksoy Y; Senen K
Atherosclerosis; 2005 Jul; 181(1):193-9. PubMed ID: 15939072
[TBL] [Abstract][Full Text] [Related]
19. Plasma concentrations of asymmetric dimethylarginine, nitric oxide and homocysteine in patients with slow coronary flow.
Yucel H; Ozaydin M; Dogan A; Erdogan D; Turker Y; Ceyhan BM; Sutcu R
Scand J Clin Lab Invest; 2012 Oct; 72(6):495-500. PubMed ID: 22950626
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of coronary microvascular function and nitric oxide synthase intron 4a/b polymorphism in patients with coronary slow flow.
Ekmekci A; Güngör B; Özcan KS; Abaci N; Ilhan E; Ekmekci SS; Kemaloğlu T; Osmonov D; Ustek D; Eren M
Coron Artery Dis; 2013 Sep; 24(6):461-7. PubMed ID: 23811833
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
